226 related articles for article (PubMed ID: 11908633)
1. Bovine lactoferrin and lactoferricin derived from milk: production and applications.
Tomita M; Wakabayashi H; Yamauchi K; Teraguchi S; Hayasawa H
Biochem Cell Biol; 2002; 80(1):109-12. PubMed ID: 11908633
[TBL] [Abstract][Full Text] [Related]
2. Lactoferricin, a new antimicrobial peptide.
Jones EM; Smart A; Bloomberg G; Burgess L; Millar MR
J Appl Bacteriol; 1994 Aug; 77(2):208-14. PubMed ID: 7961192
[TBL] [Abstract][Full Text] [Related]
3. Lactoferricin derived from milk protein lactoferrin.
Wakabayashi H; Takase M; Tomita M
Curr Pharm Des; 2003; 9(16):1277-87. PubMed ID: 12769736
[TBL] [Abstract][Full Text] [Related]
4. Expression and Purification of the Main Component Contained in Camel Milk and Its Antimicrobial Activities Against Bacterial Plant Pathogens.
Tanhaeian A; Shahriari Ahmadi F; Sekhavati MH; Mamarabadi M
Probiotics Antimicrob Proteins; 2018 Dec; 10(4):787-793. PubMed ID: 29619665
[TBL] [Abstract][Full Text] [Related]
5. Antibacterial activity in bovine lactoferrin-derived peptides.
Hoek KS; Milne JM; Grieve PA; Dionysius DA; Smith R
Antimicrob Agents Chemother; 1997 Jan; 41(1):54-9. PubMed ID: 8980754
[TBL] [Abstract][Full Text] [Related]
6. Direct evidence of the generation in human stomach of an antimicrobial peptide domain (lactoferricin) from ingested lactoferrin.
Kuwata H; Yip TT; Tomita M; Hutchens TW
Biochim Biophys Acta; 1998 Dec; 1429(1):129-41. PubMed ID: 9920391
[TBL] [Abstract][Full Text] [Related]
7. Lactoferrin and cyclic lactoferricin inhibit the entry of human cytomegalovirus into human fibroblasts.
Andersen JH; Osbakk SA; Vorland LH; Traavik T; Gutteberg TJ
Antiviral Res; 2001 Aug; 51(2):141-9. PubMed ID: 11431038
[TBL] [Abstract][Full Text] [Related]
8. Anti-complement effects of lactoferrin-derived peptides.
Samuelsen Ø; Haukland HH; Ulvatne H; Vorland LH
FEMS Immunol Med Microbiol; 2004 Jun; 41(2):141-8. PubMed ID: 15145458
[TBL] [Abstract][Full Text] [Related]
9. Antilisterial activity of dromedary lactoferrin peptic hydrolysates.
Jrad Z; El-Hatmi H; Adt I; Gouin S; Jardin J; Oussaief O; Dbara M; Arroum S; Khorchani T; Degraeve P; Oulahal N
J Dairy Sci; 2019 Jun; 102(6):4844-4856. PubMed ID: 31005319
[TBL] [Abstract][Full Text] [Related]
10. Interactions of lactoferricin-derived peptides with LPS and antimicrobial activity.
Farnaud S; Spiller C; Moriarty LC; Patel A; Gant V; Odell EW; Evans RW
FEMS Microbiol Lett; 2004 Apr; 233(2):193-9. PubMed ID: 15063486
[TBL] [Abstract][Full Text] [Related]
11. High pressure increases bactericidal activity and spectrum of lactoferrin, lactoferricin and nisin.
Masschalck B; Van Houdt R; Michiels CW
Int J Food Microbiol; 2001 Mar; 64(3):325-32. PubMed ID: 11294354
[TBL] [Abstract][Full Text] [Related]
12. Effect of lactoferricin B, a pepsin-generated peptide of bovine lactoferrin, on Escherichia coli HB101 (pRI203) entry into HeLa cells.
Longhi C; Conte MP; Bellamy W; Seganti L; Valenti P
Med Microbiol Immunol; 1994 May; 183(2):77-85. PubMed ID: 7935162
[TBL] [Abstract][Full Text] [Related]
13. Antibacterial activity of lactoferrin and a pepsin-derived lactoferrin peptide fragment.
Yamauchi K; Tomita M; Giehl TJ; Ellison RT
Infect Immun; 1993 Feb; 61(2):719-28. PubMed ID: 8423097
[TBL] [Abstract][Full Text] [Related]
14. Lactoferrin: an iron-binding antimicrobial protein against Escherichia coli infection.
Yen CC; Shen CJ; Hsu WH; Chang YH; Lin HT; Chen HL; Chen CM
Biometals; 2011 Aug; 24(4):585-94. PubMed ID: 21327478
[TBL] [Abstract][Full Text] [Related]
15. Twenty-five years of research on bovine lactoferrin applications.
Tomita M; Wakabayashi H; Shin K; Yamauchi K; Yaeshima T; Iwatsuki K
Biochimie; 2009 Jan; 91(1):52-7. PubMed ID: 18585434
[TBL] [Abstract][Full Text] [Related]
16. Lactoferricin of bovine origin is more active than lactoferricins of human, murine and caprine origin.
Vorland LH; Ulvatne H; Andersen J; Haukland H; Rekdal O; Svendsen JS; Gutteberg TJ
Scand J Infect Dis; 1998; 30(5):513-7. PubMed ID: 10066056
[TBL] [Abstract][Full Text] [Related]
17. Effect of bovine lactoferricin on enteropathogenic Yersinia adhesion and invasion in HEp-2 cells.
Di Biase AM; Tinari A; Pietrantoni A; Antonini G; Valenti P; Conte MP; Superti F
J Med Microbiol; 2004 May; 53(Pt 5):407-412. PubMed ID: 15096550
[TBL] [Abstract][Full Text] [Related]
18. Post-antibiotic effect of the antimicrobial peptide lactoferricin on Escherichia coli and Staphylococcus aureus.
Haukland HH; Vorland LH
J Antimicrob Chemother; 2001 Oct; 48(4):569-71. PubMed ID: 11581240
[TBL] [Abstract][Full Text] [Related]
19. Variation in antimicrobial activity of lactoferricin-derived peptides explained by structure modelling.
Farnaud S; Patel A; Odell EW; Evans RW
FEMS Microbiol Lett; 2004 Sep; 238(1):221-6. PubMed ID: 15336425
[TBL] [Abstract][Full Text] [Related]
20. Antibacterial activity of 15-residue lactoferricin derivatives.
Strøm MB; Rekdal O; Svendsen JS
J Pept Res; 2000 Nov; 56(5):265-74. PubMed ID: 11095180
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
